Minimal Metabolic Data Set for Patients at High Vascular Risk

Abstract

Vascular events still represent the leading cause of death in the western world. The pathogenesis of atherothrombotic events is multifactorial. Epidemiological studies indicate that the presence of several concomitant risk factors, especially in the metabolic syndrome, markedly exacerbates the vascular risk. In the prevention and management of cardiovascular disease, a multi-dimensional risk factor approach is therefore required to reduce the “vascular burden”. Consequently it is absolutely necessary to identify and to subsequently monitor these factors during intervention/therapy.

The present MMDS represents a tool for the daily clinical routine to assess and document important cardiovascular risk factors. This data set is the result of a consensus of the two German working groups of the German Cardiology Society and the German Diabetes Society. The identification and detection of all relevant vascular risk factors should result in improved patient care and a more comprehensive documentation of cardiovascular risk factors in clinical studies.

Key words

Cardiovascular disease - risk factor - prevention - structured data set

References

• 1 Guidelines for Preventing Heart Attack and Death in Patients with Atherosclerotic Cardiovascular Disease A HA/ACC. 2001 Update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology.  Circulation. 2001;  104 1577-1579
• 2 Grundy S M, Howard B, Smith S, Eckel R, Redberg R, Bonow R O. Prevention Conference VI. Diabetes and Cardiovascular Disease. Executive summary: Conference proceeding for healthcare professionals from a special writing group of the American Heart Association.  Circulation. 2002;  105 2231-2239
• 3 Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen M R, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome.  Diabet Care. 2001;  24 683-689
• 4 Norhammer A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, Malmberg K. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study.  Lancet. 2002;  359 2140-2144
• 5 Smith S C, Blair S N, Bonow R O, Brass L M, Cerqueira M D, Dracup K, Fuster V, Gotto A, Grundy S M, Miller N H, Jacobs A, Jones D, Krauss R M, Mosca L, Ockene I, Pasternak R C, Pearson T, Pfeffer M A, Starke R D, Taubert K A, Greenland P, Grundy S M. Prevention Conference V. Beyond Secondary Prevention. Identifying the high-risk patient for primary prevention executive summary.  Circulation. 2000;  101 111-116